An audit of treatment of genital warts: opening the feedback loop

M Reynolds, M Murphy, MA Waugh… - … journal of STD & …, 1993 - journals.sagepub.com
An audit of the treatment of patients (100 men and 90 women) presenting with a first episode
of anogenital warts to the Genitourinary Medicine Department at Leeds General Infirmary …

Prevalence of other sexually transmissible infections in patients with newly diagnosed anogenital warts in a sexual health clinic

EA Sturgiss, F Jin, SJ Martin, A Grulich… - Sexual …, 2010 - CSIRO Publishing
Background: Anogenital warts are a common initial presentation to the Canberra Sexual
Health Centre. It is anticipated that the introduction of human papillomavirus vaccination will …

Therapeutic options for external genital warts

R Vender, M Bourcier, N Bhatia… - Journal of cutaneous …, 2013 - journals.sagepub.com
The primary goal of treatment for external genital warts (EGWs) is to eradicate visible lesions
and address symptoms that may accompany them, but it does not address the underlying …

[PDF][PDF] Estimating prevalence of genital warts in Turkey: survey among KETEM-affiliated gynecologists across Turkey

N Ozgul, M Tuncer, M Abacioglu… - Asian Pac J Cancer Prev, 2011 - academia.edu
Abstract Background & Purpose: In order to develop cost effective health strategies
regarding HPV screening and prevention methods, determining the incidence and …

Prevalence of genital warts among sexually transmitted disease clinic patients—Sexually Transmitted Disease Surveillance Network, United States, January 2010 to …

E Llata, M Stenger, K Bernstein, S Guerry… - Sexually transmitted …, 2014 - journals.lww.com
Background A quadrivalent vaccine that prevents genital warts (GWs) has been
recommended by the Advisory Committee on Immunization Practices for women since 2007 …

Epidemiology of genital warts in the British population: implications for HPV vaccination programmes

P Sonnenberg, C Tanton, D Mesher, E King… - Sexually transmitted …, 2019 - sti.bmj.com
Objectives To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in
the British population, following the introduction of the bivalent (human papillomavirus (HPV) …

The burden and costs of prevention and management of genital disease caused by HPV in women: a population‐based registry study in Finland

H Salo, T Leino, T Kilpi, K Auranen… - … journal of cancer, 2013 - Wiley Online Library
The aim of this study was to evaluate the total burden and health care provider costs of
prevention, management and treatment of HP‐related genital disease outcomes including …

Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates

KJ Ong, M Checchi, L Burns, C Pavitt… - Sexually Transmitted …, 2019 - sti.bmj.com
Background Many economic evaluations of human papillomavirus vaccination should
ideally consider multiple disease outcomes, including anogenital warts, respiratory …

Genital warts and their treatment

KR Beutner, DJ Wiley, JM Douglas… - Clinical infectious …, 1999 - academic.oup.com
Genital warts are manifestations of a common viral sexually transmitted disease (STD) that
are often diagnosed and treated with a variety of clinical specialties. Unlike for other STDs …

Treatment of genital warts—what's the evidence?

J Wilson - International journal of STD & AIDS, 2002 - journals.sagepub.com
Genital warts are usually asymptomatic, and rarely cause discomfort. Once the patient is
aware of them the main symptom is their cosmetic appearance and resultant psychological …